Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?lookfor=%22Medical+Condition%3A+Myeloproliferative+Disorder%22&type=Subject&sort=year%2C+publishDateDaySort_date+desc%2C+id
/vufind/Search/Results?lookfor=%22Medical+Condition%3A+Myeloproliferative+Disorder%22&type=Subject&sort=year%2C+publishDateDaySort_date+desc%2C+id
Search /vufind/Search2/Results?lookfor=%22Medical+Condition%3A+Myeloproliferative+Disorder%22&type=Subject&sort=year%2C+publishDateDaySort_date+desc%2C+id
PubPharm (21)
1
A Phase I/II, Open Label Multi-Centre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the JAK2 inhibitor AZD1480 Administered Orally to Patients with Primary Myelofibrosis (PMF) and Post-Polycythaemia Vera/Essential Thrombocythaemia Myelofibrosis (Post-PV/ET MF) : A Phase I/II, Open Label Multi-Centre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the JAK2 inhibitor AZD1480 Administered Orally to Patients with Primary Myelofibrosis (PMF) and Post-Polycythaemia Vera/Essential Thrombocythaemia Myelofibrosis (Post-PV/ET MF)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
2
A Phase I/II, Open Label Multi-Centre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the JAK2 inhibitor AZD1480 Administered Orally to Patients with Primary Myelofibrosis (PMF) and Post-Polycythaemia Vera/Essential Thrombocythaemia Myelofibrosis (Post-PV/ET MF) : A Phase I/II, Open Label Multi-Centre Study to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of the JAK2 inhibitor AZD1480 Administered Orally to Patients with Primary Myelofibrosis (PMF) and Post-Polycythaemia Vera/Essential Thrombocythaemia Myelofibrosis (Post-PV/ET MF)
enthalten in:
WHO International Clinical Trials Registry Platform
| 2022
Wird geladen...
3
In Vitro Drug Sensitivity Testing of Fresh Human Samples : Evaluation of Anti-cancer Drugs Sensitivity on Fresh Samples From Healthy Patients and Patients With Myeloproliferative or Lymphoproliferative Disorders
enthalten in:
ClinicalTrials.gov
| 2022
Wird geladen...
4
Aprepitant Versus Hydroxyzine in Persistent Aquagenic Pruritus for Patients With Myeloproliferative Neoplasms : Aprepitant Versus Hydroxyzine in Association With Cytoreductive Treatments for Patients With Myeloproliferative Neoplasia Suffering From Persistent Aquagenic Pruritus.
enthalten in:
ClinicalTrials.gov
| 2021
Wird geladen...
5
Non-Myeloablative Conditioning for Unrelated Donor Umbilical Cord Blood Transplant : Transplantation of Unrelated Donor Umbilical Cord Blood in Patients With Hematological Malignancies Using a Non-Myeloablative Preparative Regimen
enthalten in:
ClinicalTrials.gov
| 2020
Wird geladen...
6
Pulmonary Hypertension in Patients With Myeloproliferative Neoplasms : Pulmonary Hypertension in Patients With Philadelphia Chromosome Negative Myeloproliferative Neoplasms; an Observational Prospective Study
enthalten in:
ClinicalTrials.gov
| 2020
Wird geladen...
7
Investigation of Dysregulated Signaling in MPD Via Multiparameter Phospho-specific Flow Cytometry : Investigation of Dysregulated Signaling in Myeloproliferative Disorders Via Multiparameter Phospho-specific Flow Cytometry
enthalten in:
ClinicalTrials.gov
| 2020
Wird geladen...
8
The NUTRIENT Trial (NUTRitional Intervention Among myEloproliferative Neoplasms): Feasibility Phase : The NUTRIENT Trial (NUTRitional Intervention Among myEloproliferative Neoplasms): Feasibility Phase
enthalten in:
ClinicalTrials.gov
| 2020
Wird geladen...
9
Clinical Characteristics of Aquagenic Pruritus in Patients With Myeloproliferative Neoplasms : Aquagenic Pruritus Among Patients With Myeloproliferative Syndromes (in English) Prurit Aquagénique Dans Les SYndromes MyéloProLifEratifs (in French)
enthalten in:
ClinicalTrials.gov
| 2019
Wird geladen...
10
A Study in Myeloproliferative Disorders : A Phase 1 Study of LY2784544 in Patients With JAK2 V617F-Positive Myeloproliferative Disorders
enthalten in:
ClinicalTrials.gov
| 2018
Wird geladen...
1
2
3
Nächster »
[3]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Medienart
21
Aufsätze
21
E-Artikel
21
E-Ressourcen
Zeitschriftentitel
19
ClinicalTrials.gov
2
WHO International Clinical Trials Registry Plat...
Thema
21
610
19
Myeloproliferative Disorders
14
Study Type: Interventional
11
Recruitment Status: Completed
7
Study Type: Observational
6
Myelodysplastic Syndromes
5
Disease
5
Phase: Phase 2
5
Polycythemia
5
Polycythemia Vera
4
Leukemia
4
Lymphoma
4
Phase: Phase 1
4
Recruitment Status: Terminated
4
Thrombocythemia, Essential
4
Thrombocytosis
3
Hypertension
3
Hypertension, Pulmonary
3
Multiple Myeloma
3
Neoplasms, Plasma Cell
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
8
2020-
13
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
21
Englisch
Haven't found what you're looking for?
Wird geladen...